Selected research
Market Outlook & Growth Opportunities
Global Deoxycholic Acid Injection Market Outlook and Growth Opportunities 2026
Market perspective
The global Deoxycholic Acid Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Deoxycholic Acid Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Deoxycholic Acid Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Deoxycholic Acid Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Deoxycholic Acid Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Deoxycholic Acid Injection market include Daewoong Pharmaceutical, Allergan and DEXLEVO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Deoxycholic Acid Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Deoxycholic Acid Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Deoxycholic Acid Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Deoxycholic Acid Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Deoxycholic Acid Injection Segment by Company
Daewoong Pharmaceutical
Allergan
DEXLEVO
Deoxycholic Acid Injection Segment by Type
10mg/mL
Other
Deoxycholic Acid Injection Segment by Application
Hospital
Clinic
Other
Deoxycholic Acid Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Deoxycholic Acid Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Deoxycholic Acid Injection market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Deoxycholic Acid Injection significant trends, drivers, influence factors in global and regions.
6. To analyze Deoxycholic Acid Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Deoxycholic Acid Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Deoxycholic Acid Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Deoxycholic Acid Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Deoxycholic Acid Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Deoxycholic Acid Injection industry.
Chapter 3: Detailed analysis of Deoxycholic Acid Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Deoxycholic Acid Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Deoxycholic Acid Injection in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg/mL
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Daewoong Pharmaceutical
- Allergan
- DEXLEVO
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Deoxycholic Acid Injection Sales Value (2021-2032)
- 1.2.2 Global Deoxycholic Acid Injection Sales Volume (2021-2032)
- 1.2.3 Global Deoxycholic Acid Injection Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Deoxycholic Acid Injection Market Dynamics
- 2.1 Deoxycholic Acid Injection Industry Trends
- 2.2 Deoxycholic Acid Injection Industry Drivers
- 2.3 Deoxycholic Acid Injection Industry Opportunities and Challenges
- 2.4 Deoxycholic Acid Injection Industry Restraints
3 Deoxycholic Acid Injection Market by Company
- 3.1 Global Deoxycholic Acid Injection Company Revenue Ranking in 2025
- 3.2 Global Deoxycholic Acid Injection Revenue by Company (2021-2026)
- 3.3 Global Deoxycholic Acid Injection Sales Volume by Company (2021-2026)
- 3.4 Global Deoxycholic Acid Injection Average Price by Company (2021-2026)
- 3.5 Global Deoxycholic Acid Injection Company Ranking (2024-2026)
- 3.6 Global Deoxycholic Acid Injection Company Manufacturing Base and Headquarters
- 3.7 Global Deoxycholic Acid Injection Company Product Type and Application
- 3.8 Global Deoxycholic Acid Injection Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Deoxycholic Acid Injection Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Deoxycholic Acid Injection Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Deoxycholic Acid Injection Market by Type
- 4.1 Deoxycholic Acid Injection Type Introduction
- 4.1.1 10mg/mL
- 4.1.2 Other
- 4.2 Global Deoxycholic Acid Injection Sales Volume by Type
- 4.2.1 Global Deoxycholic Acid Injection Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Deoxycholic Acid Injection Sales Volume by Type (2021-2032)
- 4.2.3 Global Deoxycholic Acid Injection Sales Volume Share by Type (2021-2032)
- 4.3 Global Deoxycholic Acid Injection Sales Value by Type
- 4.3.1 Global Deoxycholic Acid Injection Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Deoxycholic Acid Injection Sales Value by Type (2021-2032)
- 4.3.3 Global Deoxycholic Acid Injection Sales Value Share by Type (2021-2032)
5 Deoxycholic Acid Injection Market by Application
- 5.1 Deoxycholic Acid Injection Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Deoxycholic Acid Injection Sales Volume by Application
- 5.2.1 Global Deoxycholic Acid Injection Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Deoxycholic Acid Injection Sales Volume by Application (2021-2032)
- 5.2.3 Global Deoxycholic Acid Injection Sales Volume Share by Application (2021-2032)
- 5.3 Global Deoxycholic Acid Injection Sales Value by Application
- 5.3.1 Global Deoxycholic Acid Injection Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Deoxycholic Acid Injection Sales Value by Application (2021-2032)
- 5.3.3 Global Deoxycholic Acid Injection Sales Value Share by Application (2021-2032)
6 Deoxycholic Acid Injection Regional Sales and Value Analysis
- 6.1 Global Deoxycholic Acid Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Deoxycholic Acid Injection Sales by Region (2021-2032)
- 6.2.1 Global Deoxycholic Acid Injection Sales by Region: 2021-2026
- 6.2.2 Global Deoxycholic Acid Injection Sales by Region (2027-2032)
- 6.3 Global Deoxycholic Acid Injection Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Deoxycholic Acid Injection Sales Value by Region (2021-2032)
- 6.4.1 Global Deoxycholic Acid Injection Sales Value by Region: 2021-2026
- 6.4.2 Global Deoxycholic Acid Injection Sales Value by Region (2027-2032)
- 6.5 Global Deoxycholic Acid Injection Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Deoxycholic Acid Injection Sales Value (2021-2032)
- 6.6.2 North America Deoxycholic Acid Injection Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Deoxycholic Acid Injection Sales Value (2021-2032)
- 6.7.2 Europe Deoxycholic Acid Injection Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Deoxycholic Acid Injection Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Deoxycholic Acid Injection Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Deoxycholic Acid Injection Sales Value (2021-2032)
- 6.9.2 South America Deoxycholic Acid Injection Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Deoxycholic Acid Injection Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Deoxycholic Acid Injection Sales Value Share by Country, 2025 VS 2032
7 Deoxycholic Acid Injection Country-level Sales and Value Analysis
- 7.1 Global Deoxycholic Acid Injection Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Deoxycholic Acid Injection Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Deoxycholic Acid Injection Sales by Country (2021-2032)
- 7.3.1 Global Deoxycholic Acid Injection Sales by Country (2021-2026)
- 7.3.2 Global Deoxycholic Acid Injection Sales by Country (2027-2032)
- 7.4 Global Deoxycholic Acid Injection Sales Value by Country (2021-2032)
- 7.4.1 Global Deoxycholic Acid Injection Sales Value by Country (2021-2026)
- 7.4.2 Global Deoxycholic Acid Injection Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.9.2 France Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.16.2 China Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.19.2 India Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Deoxycholic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Deoxycholic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Deoxycholic Acid Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Daewoong Pharmaceutical
- 8.1.1 Daewoong Pharmaceutical Company Information
- 8.1.2 Daewoong Pharmaceutical Business Overview
- 8.1.3 Daewoong Pharmaceutical Deoxycholic Acid Injection Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Daewoong Pharmaceutical Deoxycholic Acid Injection Product Portfolio
- 8.1.5 Daewoong Pharmaceutical Recent Developments
- 8.2 Allergan
- 8.2.1 Allergan Company Information
- 8.2.2 Allergan Business Overview
- 8.2.3 Allergan Deoxycholic Acid Injection Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Allergan Deoxycholic Acid Injection Product Portfolio
- 8.2.5 Allergan Recent Developments
- 8.3 DEXLEVO
- 8.3.1 DEXLEVO Company Information
- 8.3.2 DEXLEVO Business Overview
- 8.3.3 DEXLEVO Deoxycholic Acid Injection Sales, Value and Gross Margin (2021-2026)
- 8.3.4 DEXLEVO Deoxycholic Acid Injection Product Portfolio
- 8.3.5 DEXLEVO Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Deoxycholic Acid Injection Value Chain Analysis
- 9.1.1 Deoxycholic Acid Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Deoxycholic Acid Injection Sales Mode & Process
- 9.2 Deoxycholic Acid Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Deoxycholic Acid Injection Distributors
- 9.2.3 Deoxycholic Acid Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst